Literature DB >> 26791876

Analysis and performance of various classification criteria sets in a Colombian cohort of patients with spondyloarthritis.

Wilson Bautista-Molano1,2, Robert B M Landewé3, John Londoño4,5, Consuelo Romero-Sanchez4, Rafael Valle-Oñate3, Désirée van der Heijde6.   

Abstract

The objective of this study was to investigate the performance of classification criteria sets (Assessment of SpondyloArthritis international Society (ASAS), European Spondylarthropathy Study Group (ESSG), and Amor) for spondyloarthritis (SpA) in a clinical practice cohort in Colombia and provide insight into how rheumatologists follow the diagnostic path in patients suspected of SpA. Patients with a rheumatologist's diagnosis of SpA were retrospectively classified according to three criteria sets. Classification rate was defined as the proportion of patients fulfilling a particular criterion. Characteristics of patients fulfilling and not fulfilling each criterion were compared. The ASAS criteria classified 81 % of all patients (n = 581) as having either axial SpA (44 %) or peripheral SpA (37 %), whereas a lower proportion met ESSG criteria (74 %) and Amor criteria (53 %). There was a high degree of overlap among the different criteria, and 42 % of the patients met all three criteria. Patients fulfilling all three criteria sets were older (36 vs. 30 years), had more SpA features (3 vs. 1 features), and more frequently had a current or past history of back pain (77 vs. 43 %), inflammatory back pain (47 vs. 13 %), enthesitis (67 vs. 26 %), and buttock pain (37 vs. 13 %) vs. those not fulfilling any criteria. HLA-B27, radiographs, and MRI-SI were performed in 77, 59, and 24 % of the patients, respectively. The ASAS criteria classified more patients as having SpA in this Colombian cohort when the rheumatologist's diagnosis is used as an external standard. Although physicians do not perform HLA-B27 or imaging in all patients, they do require these tests if the clinical symptoms fall short of confirming SpA and suspicion remains.

Entities:  

Keywords:  Classification criteria; Clinical practice; Cohort; Performance; Spondyloarthritis

Mesh:

Substances:

Year:  2016        PMID: 26791876     DOI: 10.1007/s10067-016-3184-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  31 in total

1.  Nonradiographic axial spondyloarthritis. What brings the new concept?

Authors:  E Collantes-Estevez; Luis R Espinoza; Luis R Espinosa
Journal:  Clin Rheumatol       Date:  2014-10-21       Impact factor: 2.980

Review 2.  Seronegative arthritis in Latin America: a current review.

Authors:  Carla Gonçalves Schain Saad; Célio Roberto Gonçalves; Percival D Sampaio-Barros
Journal:  Curr Rheumatol Rep       Date:  2014       Impact factor: 4.592

3.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

4.  The risk of developing ankylosing spondylitis in HLA-B27 positive individuals: a family and population study.

Authors:  S van der Linden; H Valkenburg; A Cats
Journal:  Br J Rheumatol       Date:  1983-11

5.  Performance of the assessment in Spondyloarthritis International Society classification for axial and peripheral spondyloarthritis in an established clinical cohort: comparison with criteria sets of Amor and the European Spondylarthropathy Study Group.

Authors:  Peter P Cheung; Simon Paternotte; Vincent Burki; Anne Durnez; Muriel Elhai; Isabelle Fabreguet; Eugenie Koumakis; Magali Meyer; Judith Payet; Fanny Roure; Maxime Dougados; Laure Gossec
Journal:  J Rheumatol       Date:  2012-02-15       Impact factor: 4.666

6.  The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general.

Authors:  M Rudwaleit; D van der Heijde; R Landewé; N Akkoc; J Brandt; C T Chou; M Dougados; F Huang; J Gu; Y Kirazli; F Van den Bosch; I Olivieri; E Roussou; S Scarpato; I J Sørensen; R Valle-Oñate; U Weber; J Wei; J Sieper
Journal:  Ann Rheum Dis       Date:  2010-11-24       Impact factor: 19.103

7.  The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.

Authors:  M Rudwaleit; D van der Heijde; R Landewé; J Listing; N Akkoc; J Brandt; J Braun; C T Chou; E Collantes-Estevez; M Dougados; F Huang; J Gu; M A Khan; Y Kirazli; W P Maksymowych; H Mielants; I J Sørensen; S Ozgocmen; E Roussou; R Valle-Oñate; U Weber; J Wei; J Sieper
Journal:  Ann Rheum Dis       Date:  2009-03-17       Impact factor: 19.103

8.  The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy.

Authors:  M Dougados; S van der Linden; R Juhlin; B Huitfeldt; B Amor; A Calin; A Cats; B Dijkmans; I Olivieri; G Pasero
Journal:  Arthritis Rheum       Date:  1991-10

9.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

10.  Performance of the Assessment of Spondyloarthritis International Society criteria for the classification of spondyloarthritis in early spondyloarthritis clinics participating in the ESPERANZA programme.

Authors:  Eva Tomero; Juan Mulero; Eugenio de Miguel; Cruz Fernández-Espartero; Milena Gobbo; Miguel A Descalzo; Eduardo Collantes-Estévez; Pedro Zarco; Santiago Muñoz-Fernández; Loreto Carmona
Journal:  Rheumatology (Oxford)       Date:  2013-11-05       Impact factor: 7.580

View more
  3 in total

1.  Spartan annual meeting: Denver, Colorado.

Authors:  Luis R Espinoza
Journal:  Clin Rheumatol       Date:  2016-06       Impact factor: 2.980

Review 2.  Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis.

Authors:  Gustavo Citera; Wilson Bautista-Molano; Ingris Peláez-Ballestas; Valderilio F Azevedo; Risto A Perich; José A Méndez-Rodríguez; Mariel S Cutri; Cecilia E Borlenghi
Journal:  Adv Rheumatol       Date:  2021-01-08

3.  Gastrointestinal Symptoms and Elevated Levels of Anti-Saccharomyces cerevisiae Antibodies Are Associated with Higher Disease Activity in Colombian Patients with Spondyloarthritis.

Authors:  C Romero-Sánchez; W Bautista-Molano; V Parra; J De Avila; J C Rueda; J M Bello-Gualtero; J Londoño; R Valle-Oñate
Journal:  Int J Rheumatol       Date:  2017-10-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.